Think about your upcoming biotech investor presentation. Chances are you have pored over the slide deck but spent little time thinking about how you will share the content. Few issues are more important to preclinical–stage biotech companies than maintaining a continuous flow of capital.
If you plan to advance the development of your product with capital, you need to attract and maintain investor interest, which involves continuously pitching venture capitalists and investors. The best biotech presentations possess this combination of speaking skills:
Integrate a succinct themed presentation with punctuated gestures.
Before you dismiss the idea of gestures as being unnecessary for investor presentations, we will share the latest research on how to create persuasive messaging combined with gestures to help secure the capital you need for continued growth.
As an organization prepares for an investor presentation, little time is typically allocated to analysis and creation of the primary theme. Biotech CEOs can get caught in the weeds, providing too much detail. As a result, investors begin to lose interest in the presentation. Biotech CEOs must craft a presentation that has a memorable theme that is different from the competition.
In our research at The Speech Improvement Company, with hundreds of our Biotech and Life Sciences clients, we were struck by our observations that Biotech CEO’s have difficulty drilling down to a single theme for their product during an investor pitch. What became clear was the difficulty in distilling data into one core theme. If you can condense your entire presentation into one sentence with a strong primary theme, you are on the right track. (more…)